ID   HEK293 GOT2 KO clone A7
AC   CVCL_C3NI
DR   ABM; T6426
DR   Wikidata; Q116049301
RX   PubMed=31422819;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 4433; GOT2.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=31422819; DOI=10.1016/j.ajhg.2019.07.015;
RA   van Karnebeek C.D.M., Ramos R.J., Wen X.-Y., Tarailo-Graovac M.,
RA   Gleeson J.G., Skrypnyk C., Brand-Arzamendi K., Karbassi F., Issa M.Y.,
RA   van der Lee R., Drogemoller B.I., Koster J., Rousseau J.,
RA   Campeau P.M., Wang Y.-D., Cao F., Li M., Ruiter J., Ciapaite J.,
RA   Kluijtmans L.A.J., Willemsen M.A.A.P., Jans J.J.M., Ross C.J.D.,
RA   Wintjes L.T., Rodenburg R.J., Huigen M.C.D.G., Jia Z.-P., Waterham H.R.,
RA   Wasserman W.W., Wanders R.J.A., Verhoeven-Duif N.M., Zaki M.S.,
RA   Wevers R.A.;
RT   "Bi-allelic GOT2 mutations cause a treatable malate-aspartate
RT   shuttle-related encephalopathy.";
RL   Am. J. Hum. Genet. 105:534-548(2019).
//